Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MTD · against 76 other Healthcare companies of similar size
Ranked #48 of 77 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score20 peers with a valuation score of 50–59, including MTD · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MTD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 73 reported | 2.6% | 2.9% | 46% | 30% | |
| EBITDA yieldHigher is better · 78 reported | 3.5% | 5.2% | 25% | 50% | |
| Free cash flow yieldHigher is better · 53 reported | 2.5% | 3.9% | 25% | 20% | |
| Book yieldHigher is better · 72 reported | 0.0% | 20.1% | 3% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 46 | 49.5B USD | 53 | 53 | |
| 47 | 21.7B USD | 52 | 32 | |
| 48 | 34.6B USD | 51 | 58 | |
| 48 | 18.5B USD | 51 | 62 | |
| 48 | 34.0B USD | 51 | 49 | |
| 51 | 67.60T KRW (≈$48.7B) | 50 | 72 | |
| 51 | 36.0B USD | 50 | 46 | |
| 51 | 38.4B USD | 50 | 50 | |
| 54 | 327.3B CNY (≈$45.8B) | 49 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score